Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,749.10
-24.90 (-1.40%)
Nov 28, 2025, 10:40 AM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 292.28 billion as of November 26, 2025. Its market cap has decreased by -1.65% in one year.
Market Cap
292.28B
Enterprise Value
263.28B
Revenue
58.01B
Ranking
n/a
PE Ratio
36.97
Stock Price
1,749.10
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 292.28B, a decrease of -1.62%. That is a compound annual growth rate of -0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 292.28B | -0.30% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.26T |
| Divi's Laboratories | 1.73T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 934.29B |
| Mankind Pharma | 925.36B |
| Aurobindo Pharma | 712.88B |
| Fortis Healthcare | 694.86B |